AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2018
Feb 13, 2018
35134_dirs_2018-02-12_9ce34c57-29b6-4e86-82a2-121a64b73be6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2017-12-31
Reporting Person: Finizio Robert G (Director, CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-01 | Common Stock | G | 250000 | — | Disposed | 18393559 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1630090 | Indirect |
| Common Stock | 369910 | Indirect |
Footnotes
F1: By the reporting person's Grantor-Retained Annuity Trust (the "GRAT").
F2: Includes 197,350 shares of common stock previously reported as being held indirectly by the GRAT.
F3: By Robert Finizio Revocable Trust.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16